Prediction of Pathologic Complete Response by Gene Expression Profiling in Esopha
Principal Investigator: Jaffer Ajani
Affiliation: The University of Texas
Abstract: DESCRIPTION (provided by applicant): Our objective is to develop a PCR-based ~10-gene signature, through gene expression analyses, that can predict all three subtypes of pathologic responses (with high accuracy) following chemoradiation therapy in patients with esophageal cancer who undergo chemoradiation followed by surgery (Tri-modality [TM] therapy). The three pathologic subtypes are: pathologic complete response (pathCR), partial response, and extreme chemoradiation-resistance (exCRTR). One can conceive a therapeutic approach suited for each outcome (e.g., avoid chemoradiation in patients whose cancer has an exCRTR). Today however, there are no tools to optimize therapy for these outcomes since we cannot predict them before therapy. A predictive signature that has a high level (=80%) of specificity and a reasonable level of sensitivity (=45%) would be an advance. Our hypothesis is that a practical molecular signature can be established through gene expression profiling to predict three subgroups prior to TM therapy. In our 19-patient gene expression profiling study, the unsupervised hierarchical cluster analysis segregated cancers into two subtypes. Five of 6 pathCR patients clustered in subtype I and one pathCR patient clustered in subtype II. We discovered that Sonic Hedgehog and NF-kB-related genes appear to mediate chemoradiation-resistance. We were able to independently validate this. In a gene expression analysis of 47 TM patients (Specific Aim 0), we used 17 genes (10% false-discovery rate) to construct a multivariate model to predict response. For each gene g, we first computed the residuals Rg,i from a linear model of the form , where Yg,i is the expression of gene g in sample i, t(i) is the subtype of sample i, and Sg,t(i) is the mean expression of gene g in samples of that subtype. We then used the residuals as predictors in an ordinal regression model to predict the outcome categories. We used the Akaike Information Criterion (AIC) to remove unnecessary variables from the model. The final model involved 7 genes: RiskScore=1.59 TMEM46 + 0.68 THBS1 -1.52 LOC442578 - 2.14 SRM 1.16 CHST4 + 0.83 DES + 1.14 SDS, with a cutoff between pathCR and partial response at -1.56 and a cutoff between partial response and exCRTR at 3.72. Four of these seven genes are related to Sonic Hedgehog pathway and 2 are NF-kB targets. In this proposal, data from 120 TM patients to be analyzed through a funded grant (R21CA127612) will be added to a new cohort of 120 TM patients (Specific Aim 1) to establish a large (n=240) training (discovery) set. We will identify best performing ~100 genes through microfluidic card technology. Specific Aim 2 will validate ~100 best genes and refine the model to select ~10 best performing genes for predicting three outcomes. Specific Aim 3 will prospectively validate the ~10-gene signature. A continuous "risk score" for the outcome will be computed. Specificity and sensitivity will be determined by generating receiver-operating (ROC) curves for optimizing the prediction boundaries. PUBLIC HEALTH RELEVANCE: This proposal is an early attempt to individualize therapy based on molecular biology for patients with esophageal cancer. Our goal is to pave the way for a strategy in the future that will allow administration of effective therapy, improve safety, and preserve the esophagus in some patients.
Funding Period: -------------------- - --------------------
more information: NIH RePORT
- Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like PropertiesShumei Song
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Cancer Res 74:4170-82. 2014..Cancer Res; 74(15); 4170-82. ©2014 AACR. ..
- ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patientsJ A Ajani
Department of Gastrointestinal Medical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, USA Electronic address
Mol Oncol 8:142-9. 2014..We hypothesized that aldehyde dehydrogenase-1 (ALDH-1) could be associated with response...
- Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategiesKazuki Sudo
All authors The University of Texas MD Anderson Cancer Center, Houston, TX
J Clin Oncol 31:4306-10. 2013..However, the benefits of surveillance are not well understood. We report on LRFs and salvage strategies in a large cohort...
- Gastric cancer-molecular and clinical dimensionsRoopma Wadhwa
Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard FC10 3022, Houston, TX 77030, USA
Nat Rev Clin Oncol 10:643-55. 2013..However, many challenges remain to be tackled. Here, we review representative molecular and clinical dimensions of gastric cancer. ..
- Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinomaEnping Xu
Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Carcinogenesis 34:2750-6. 2013..8 for each validated gene). The differentially methylated genes and pathways may provide biological insights into the development and progression of BE and become potential biomarkers for the prediction and early detection of EAC. ..
- Risk assessment of esophageal adenocarcinoma using γ-H2AX assayEnping Xu
Authors Affiliations Departments of Epidemiology and Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas and Department of Pathology, School of Medicine, Zhejiang University, Hangzhou, People s Republic of China
Cancer Epidemiol Biomarkers Prev 22:1797-804. 2013..The formation of γ-H2AX is an early cellular response to DNA double-strand breaks (DSB). We hypothesize that higher level of radiation-induced γ-H2AX in PBLs may be associated with an increased risk of esophageal adenocarcinoma...
- MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinomaXifeng Wu
Department of Epidemiology, Unit 1340, The University of Texas MD Anderson Cancer Center, 1155 Pressler Boulevard, Houston, TX 77030, USA
Cancer Prev Res (Phila) 6:196-205. 2013....
- The role of microRNAs in cancers of the upper gastrointestinal tractShumei Song
Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Nat Rev Gastroenterol Hepatol 10:109-18. 2013..In-depth studies of miRNAs in UGICs might yield novel insights and potential novel therapeutic strategies...
- The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapyYuki Hayashi
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 116:5619-27. 2010..Its influence on a patient's outcome remains unclear. In the current study, the authors examined the impact of BMI on survival and complications in patients with esophageal cancer (EC) who underwent surgery as their primary therapy...
- Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experiencePanteleimon Kountourakis
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 117:925-30. 2011..This study analyzed the largest series of consecutive cT2N0M0 esophageal cancer patients treated with preoperative chemoradiotherapy...
- Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapyAkihiro Suzuki
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Cancer 117:4823-33. 2011..The authors hypothesized that initial SUV would correlate with patient outcome...
- Gene expression signature-based prognostic risk score in gastric cancerJae Yong Cho
Department of Systems Biology, Division of Cancer Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas 77054, USA
Clin Cancer Res 17:1850-7. 2011..We aim to develop practical biomarker-based risk score that can predict relapse of gastric cancer after surgical treatment...